Michela Cimberle's profile photo

Michela Cimberle

Veneto

Senior Staff Writer at Healio Ophthalmology

Senior Staff Writer at Healio

Articles

  • 1 week ago | healio.com | Michela Cimberle

    Key takeaways: One specialist proposed that new-generation anti-VEGFs show better efficacy. Another said there is a lack of high-level evidence in this area. SEVILLE, Spain — Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature. It is often difficult to treat, requires a higher than average number of injections and can often lead to retinal pigment epithelial (RPE) tears.

  • 1 week ago | healio.com | Michela Cimberle |Christine Klimanskis |Nancy M. Holekamp |Rodrigo Gonzalez |Rodrigo González

    Key takeaways: One presenter said at-home OCT has the potential to improve outcomes in neovascular AMD through personalized care. Another said there are still barriers to overcome with monitoring programs. SEVILLE, Spain — Home monitoring of neovascular age-related macular degeneration, an interesting concept with many potential benefits, has entered the retina space in the U.S. with the Scanly Home OCT monitoring program from Notal Vision.

  • 2 weeks ago | healio.com | Michela Cimberle |Christine Klimanskis

    Key takeaways:One specialist argued that, in the future, gene therapy technologies will be the favored option for wet AMD. Another emphasized that there are still challenges and limitations that need to be overcome. SEVILLE, Spain — Gene therapy is an area of intensive research and development in the retina space, with promising prospects and significant challenges. The benefits and pitfalls of gene therapy were discussed by two specialists at the Congress on Controversies in Ophthalmology.

  • 2 weeks ago | healio.com | Michela Cimberle |Christine Klimanskis

    Key takeaways:One presenter said there is sufficient evidence supporting atropine to slow myopia progression. Another said inconsistent study designs do not support atropine as the standard of care. SEVILLE, Spain — Whether atropine should be the standard of care for halting myopia progression was a hot topic discussed at the Congress on Controversies in Ophthalmology.

  • 2 weeks ago | healio.com | Anat Loewenstein |Baruch D. Kuppermann |Michela Cimberle

    SEVILLE, Spain — In this Healio Video Perspective, Anat Loewenstein, MD, MHA, and Baruch D. Kuppermann, MD, PhD, highlight topics discussed at the Congress on Controversies in Ophthalmology. “We’ve had a lot of interesting debates with great participation all around,” Kuppermann said. Basic research, emerging therapies, futuristic approaches and pragmatic management issues were addressed from different perspectives in the fields of retina, glaucoma, neuro-ophthalmology and uveitis.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map